$LIVN (LivaNova PLC)

$LIVN {{ '2016-07-29T08:36:51+0000' | timeago}} • Announcement

$LIVN said it elected Andrea Saia to its BoD as a non-executive director. Saia brings considerable board and healthcare credentials to $LIVN following 11 years with $NVS as President and CEO of their CIBAVision subsidiary and as global head of their Vision Care Division.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$LIVN {{ '2017-07-12T12:45:32+0000' | timeago}} • Announcement

$LIVN appointed Keyna Skeffington as SVP and General Counsel. Skeffington most recently served as Vice President of Legal – Corporate and Securities, Deputy General Counsel and Assistant Secretary at $MDT.

$MDT {{ '2017-07-10T15:43:07+0000' | timeago}} • Announcement

$MDT announced the expanded FDA approval of the self-expanding CoreValve Evolut transcatheter aortic valve replacement platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery.

$DXC {{ '2017-07-05T13:22:08+0000' | timeago}} • Announcement

$DXC has acquired Tribridge, an independent integrators of Microsoft Dynamics 365. The acquisition includes the Tribridge affiliate company, Concerto Cloud Services. Under the agreement, which is effective immediately, Tribridge will be known as Tribridge, a DXC Technology Company. Financial terms were not disclosed.

$XPER {{ '2017-07-05T13:11:54+0000' | timeago}} • Announcement

$XPER business Tessera Technologies said the US International Trade Commission has issued a favorable order on the company’s patent infringement dispute with $BRCM. Tessera’s counsel has confirmed the broad scope of the company’s victory in the lawsuit, related mainly to infringement of patents of semiconductor chips.

$AOBC {{ '2017-06-30T13:55:31+0000' | timeago}} • Webcast

$AOBC said its internal inventory levels were slightly elevated in 4Q17, mainly in firearms, and the Smith & Wesson maker expects those levels to continue rising over the next several months building inventory for the fall hunting and holiday season.

$AOBC {{ '2017-06-30T13:44:51+0000' | timeago}} • Webcast

As $AOBC posted 4Q17 results, the company said, "we expect the seasonal impact on our revenue to be much more pronounced in the first-half of fiscal 2018"

$AOBC {{ '2017-06-30T13:37:56+0000' | timeago}} • Webcast

Regarding $AOBC's 500,000-square foot distribution center in Missouri, construction expected to take at least 18 months and the entire project requiring two to three years to complete, the company announced as it posted 4Q17 results.

$MASI {{ '2017-06-30T12:41:36+0000' | timeago}} • Announcement

Medical technology firm $MASI entered into a partnership with Midmark Corp. for enhancing the accuracy and efficiency of vital signs acquisition in the clinical space. Under the deal, Masimo’s SET pulse oximetry technology is an available option with Midmark's IQvitals Zone. The combination provides accurate and real-time vital signs information.

$AOBC {{ '2017-06-29T20:34:15+0000' | timeago}} • Infographic

$AOBC American Outdoor Brands Corporation Earnings AlphaGraphic: Q4 2017 Highlights

$AOBC {{ '2017-06-29T20:28:56+0000' | timeago}} • Announcement

In FY18, $AOBC expects to continue employing strength of its balance sheet, including unused portion of its revolving line of credit, which is expandable up to $500MM, to fuel additional growth opportunities, both organic and inorganic.

$AOBC {{ '2017-06-29T20:27:11+0000' | timeago}} • Announcement

$AOBC expects 1Q18 net sales of $140-150MM, EPS of $0.01-0.06 and non-GAAP EPS of $0.07-0.12. For the full year 2018, the company predicts net sales of $750-790MM, EPS of $1.16-1.36 and non-GAAP EPS of $1.42-1.62.

$AOBC {{ '2017-06-29T20:25:15+0000' | timeago}} • Announcement

$AOBC reported a drop in 4Q17 earnings due to higher costs and expenses. Net income fell to $27.69MM or $0.50 per share from $35.65MM or $0.63 per share last year. Net sales grew to $229.19MM from $221.12MM, on growth in its Firearms and Outdoor products and accessories segments. Non-GAAP EPS decreased to $0.57 from $0.66.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, June 29 2017 - 9:00pm
HOME (At Home Group Inc.)
Wednesday, June 7 2017 - 12:30pm
DXC (DXC Technology Company)
Thursday, May 25 2017 - 9:00pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
HAE (Haemonetics Corporation)
Monday, May 8 2017 - 12:00pm
SRCI (SRC Energy Inc.)
Friday, May 5 2017 - 3:00pm
VREX (Varex Imaging Corporation)
Thursday, May 4 2017 - 9:00pm
OFIX (Orthofix International N.V.)
Thursday, May 4 2017 - 8:30pm
BIVV (Bioverativ Inc.)
Thursday, May 4 2017 - 12:00pm
XPER (Xperi Corporation)
Wednesday, May 3 2017 - 9:00pm
FIT (Fitbit Inc.)
Wednesday, May 3 2017 - 9:00pm
WMGI (Wright Medical Group N.V.)
Wednesday, May 3 2017 - 8:30pm
MASI (Masimo Corporation)
Wednesday, May 3 2017 - 8:30pm
LIVN (LivaNova PLC)
Wednesday, May 3 2017 - 1:00pm
TVTY (Tivity Health, Inc.)
Thursday, April 27 2017 - 9:00pm
RTIX (RTI Surgical Inc.)
Thursday, April 27 2017 - 12:30pm
FTI (TechnipFMC plc)
Thursday, April 27 2017 - 12:00pm
CRY (CryoLife Inc.)
Thursday, April 27 2017 - 12:00pm
NUVA (NuVasive, Inc.)
Tuesday, April 25 2017 - 8:30pm

AlphaGraphics you may like